{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:17:26Z","timestamp":1783664246195,"version":"3.55.0"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008021","name":"Fujian University of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>\n                    Although Atopic Dermatitis (AD) and Attention-Deficit\/Hyperactivity Disorder (ADHD) frequently coexist in children, th\n                    <jats:underline>e<\/jats:underline>\n                    underlying mechanisms remain unclear. The \u201cSkin-Brain Axis\u201d(SBA) hypothesis, based on the shared ectodermal origin of the skin and the central nervous system(CNS), provides a theoretical foundation for communication between AD and ADHD. However, standardized biomarkers and direct clinical validation are currently lacking. Interleukin-4 (IL-4), a key cytokine driving skin inflammation in AD, may theoretically influence CNS development via the SBA, thereby contributing to the pathophysiology of ADHD; but this hypothesis has not yet been validated in humans. Based on the SBA, the review integrates the dual role of IL-4 in the pathogenesis of AD and ADHD, explores the possibility of IL-4 acting as a bridging signal between peripheral skin inflammation and neurodevelopmental abnormalities, and summarizes existing clinical and preclinical evidence for IL-4-targeted therapies for AD-ADHD comorbidity, while also highlighting current gaps in evidence and limitations in application. Future research should include prospective clinical trials with neurocognitive assessment and brain imaging as endpoints, using direct neuroimmune effects and indirect effects (such as itch relief and improved sleep) as reference indicators, to systematically evaluate the feasibility of IL-4 inhibitors in controlling neurobehavioral symptoms and provide a practical research pathway for clinical translation.\n                  <\/jats:p>","DOI":"10.3389\/falgy.2026.1887240","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:39:41Z","timestamp":1783661981000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The potential of targeted IL-4 therapy for the comorbidity of atopic dermatitis and attention-deficit\/hyperactivity disorder in children via the skin-brain axis"],"prefix":"10.3389","volume":"7","author":[{"given":"Yingjie","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Dermatology, The First Clinical Medical College of Beijing University of Chinese Medicine (Dongzhimen Hospital)","place":["Beijing, China"]},{"name":"Fujian Provincial Key Laboratory of Integrative Dermatology, The Second Affiliated Hospital of Fujian University of Chinese Medicine","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Pediatric, Dongfang Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weisheng","family":"Hu","sequence":"additional","affiliation":[{"name":"Fujian Provincial Key Laboratory of Integrative Dermatology, The Second Affiliated Hospital of Fujian University of Chinese Medicine","place":["Fuzhou, Fujian, China"]},{"name":"College of Chinese Medicine, Chengdu University of Traditional Chinese Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijia","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pediatric, Dongfang Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Huang","sequence":"additional","affiliation":[{"name":"Fujian Provincial Key Laboratory of Integrative Dermatology, The Second Affiliated Hospital of Fujian University of Chinese Medicine","place":["Fuzhou, Fujian, China"]},{"name":"Department of Dermatology, The Second Affiliated Hospital of Fujian University of Chinese Medicine","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0140-6736(24)02519-4","article-title":"Atopic dermatitis","volume":"405","author":"Guttman-Yassky","year":"2025","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/all.13401","article-title":"Epidemiology of atopic dermatitis in adults: results from an international survey","volume":"73","author":"Barbarot","year":"2018","journal-title":"Allergy"},{"key":"B3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/jdv.19686","article-title":"Epidemiology of mental health comorbidity in patients with atopic dermatitis: an analysis of global trends from 1998 to 2022","volume":"38","author":"Cai","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S2213-2600(25)00003-7","article-title":"Global, regional, and national burden of asthma and atopic dermatitis, 1990\u20132021, and projections to 2050: a systematic analysis of the global burden of disease study 2021","volume":"13","year":"2025","journal-title":"Lancet Respir Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1192\/j.eurpsy.2024.1786","article-title":"Prevalence of attention-deficit hyperactivity disorder (ADHD): systematic review and meta-analysis","volume":"67","author":"Popit","year":"2024","journal-title":"Eur Psychiatry J Assoc Eur Psychiatr"},{"key":"B6","first-page":"13","article-title":"Prevalence and related factors of attention deficit hyperactivity disorder in school-age children with atopic dermatitis","volume":"30","author":"Yu","year":"2024","journal-title":"Altern Ther Health Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2058738420962902","DOI":"10.1177\/2058738420962902","article-title":"Childhood atopic dermatitis as a precursor for developing attention deficit\/hyperactivity disorder","volume":"34","author":"Xu","year":"2020","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"100906","DOI":"10.1016\/j.bbih.2024.100906","article-title":"Skin-brain dialogue in auto-inflammatory diseases: a new route to biomarkers?","volume":"42","author":"Matar","year":"2024","journal-title":"Brain Behav Immun-Health"},{"key":"B9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41380-022-01829-8","article-title":"Ectodermal origins of the skin-brain axis: a novel model for the developing brain, inflammation, and neurodevelopmental conditions","volume":"28","author":"Jameson","year":"2023","journal-title":"Mol Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbi.2020.12.003","article-title":"IL-4R\u03b1 deletion disrupts psychomotor performance and reference memory in mice while sparing behavioural phenotype associated with spatial learning","volume":"92","author":"Brombacher","year":"2021","journal-title":"Brain Behav Immun"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1016\/j.neuron.2023.09.031","article-title":"IL-4 shapes microglia-dependent pruning of the cerebellum during postnatal development","volume":"111","author":"Guedes","year":"2023","journal-title":"Neuron"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e16266","DOI":"10.1111\/jnc.16266","article-title":"Early-life IL-4 administration induces long-term changes in microglia in the cerebellum and prefrontal cortex","volume":"169","author":"Ferreira","year":"2025","journal-title":"J Neurochem"},{"key":"B13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3892\/ijmm.2025.5654","article-title":"Changes in the endoplasmic reticulum-mitochondria communication in dermal fibroblasts from early-stage bipolar disorder patients: skin-brain axis as a new route to understand the pathophysiology of mental illness?","volume":"56","author":"Pereira","year":"2025","journal-title":"Int J Mol Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3390\/genes16121463","article-title":"From skin to brain: key genetic mediators associating cutaneous inflammation and neurodegenerative diseases","volume":"16","author":"Grech","year":"2025","journal-title":"Genes (Basel)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.7499\/j.issn.1008-8830.2503118","article-title":"The microbiota-gut-brain axis in childhood attention-deficit\/hyperactivity disorder: mechanisms and therapeutic advances","volume":"27","author":"Yuan","year":"2025","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi Chin J Contemp Pediatr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"100279","DOI":"10.1016\/j.bbih.2021.100279","article-title":"Skin-brain axis signaling mediates behavioral changes after skin wounding","volume":"15","author":"Fregoso","year":"2021","journal-title":"Brain Behav Immun-Health"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1414457","DOI":"10.3389\/fnmol.2024.1414457","article-title":"Age-related changes in the architecture and biochemical markers levels in motor-related cortical areas of SHR rats-an ADHD animal model","volume":"17","author":"Bogda\u0144ska-Chomczyk","year":"2024","journal-title":"Front Mol Neurosci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"eadn9390","DOI":"10.1126\/science.adn9390","article-title":"Scratching promotes allergic inflammation and host defense via neurogenic mast cell activation","volume":"387","author":"Liu","year":"2025","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3389\/fimmu.2018.00888","article-title":"Tuning the cytokine responses: an update on interleukin (IL)-4 and IL-13 receptor complexes","volume":"9","author":"Junttila","year":"2018","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1068260","DOI":"10.3389\/fimmu.2022.1068260","article-title":"JAK\u2013STAT signaling pathway in the pathogenesis of atopic dermatitis: an updated review","volume":"13","author":"Huang","year":"2022","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1254\/fpj.25008","article-title":"Mechanism of pathogenesis by a gain-of-function variant of STAT6 causing severe allergic diseases and potential for development of molecularly targeted drugs","volume":"160","author":"Yanagi","year":"2025","journal-title":"Nihon Yakurigaku Zasshi Folia Pharmacol Jpn"},{"key":"B22","doi-asserted-by":"publisher","first-page":"108348","DOI":"10.1016\/j.pharmthera.2023.108348","article-title":"Interleukin-4 as a therapeutic target","volume":"242","author":"G\u00e4rtner","year":"2023","journal-title":"Pharmacol Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jaci.2016.07.012","article-title":"IL-4 impairs wound healing potential in the skin by repressing fibronectin expression","volume":"139","author":"Serezani","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/all.70060","article-title":"Distinct roles of IL-4, IL-13, and IL-22 in human skin barrier dysfunction and atopic dermatitis","volume":"81","author":"D\u2019Avino","year":"2026","journal-title":"Allergy"},{"key":"B25","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/cells13090760","article-title":"JAK\/STAT inhibition normalizes lipid composition in 3D human epidermal equivalents challenged with Th2 cytokines","volume":"13","author":"Flori","year":"2024","journal-title":"Cells"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1387128","DOI":"10.3389\/fphys.2025.1387128","article-title":"Effects of Th1\/Th17 and Th2 cytokines on lipid metabolism in differentiated keratinocytes","volume":"16","author":"Cavallo","year":"2025","journal-title":"Front Physiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e2100749118","DOI":"10.1073\/pnas.2100749118","article-title":"Interleukins 4 and 13 drive lipid abnormalities in skin cells through regulation of sex steroid hormone synthesis","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B28","doi-asserted-by":"publisher","first-page":"vkaf283.2311","DOI":"10.1093\/jimmun\/vkaf283.2311","article-title":"Blood-brain barrier-crossing IL-4 for treatment of neuroinflammatory disease 4663","volume":"214","author":"Kane Berg","year":"2025","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s41423-023-01043-8","article-title":"Type 2 immunity in the brain and brain borders","volume":"20","author":"Mamuladze","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.4049\/jimmunol.1202246","article-title":"IL-4 in the brain: a cytokine to remember","volume":"189","author":"Gadani","year":"2012","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s10571-023-01451-4","article-title":"Neonatal IL-4 over-exposure is accompanied by macrophage accumulation in Dura mater after instant anti-inflammatory cytokine response in CSF","volume":"44","author":"Wang","year":"2024","journal-title":"Cell Mol Neurobiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s13555-025-01352-y","article-title":"Interleukin-4 and atopic dermatitis: why does it matter?","volume":"15","author":"Torres","year":"2025","journal-title":"A Narrative Review. Dermatol Ther"},{"key":"B33","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3390\/cells13050425","article-title":"Unraveling atopic dermatitis: insights into pathophysiology, therapeutic advances, and future perspectives","volume":"13","author":"Pareek","year":"2024","journal-title":"Cells"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.3390\/ijms20174070","article-title":"Antagonistic effects of IL-4 on IL-17A-mediated enhancement of epidermal tight junction function","volume":"20","author":"Brewer","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jdermsci.2023.06.006","article-title":"Reversine enhances skin barrier functions by suppressing the IL-4- and IL-13-mediated STAT6 pathway","volume":"111","author":"Park","year":"2023","journal-title":"J Dermatol Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e149953","DOI":"10.1172\/jci.insight.149953","article-title":"Basophil-derived IL-4 promotes cutaneous Staphylococcus aureus infection","volume":"6","author":"Leyva-Castillo","year":"2021","journal-title":"JCI Insight"},{"key":"B37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","article-title":"Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch","volume":"171","author":"Oetjen","year":"2017","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jdermsci.2022.04.002","article-title":"An epidermal keratinocyte homogenate induced type 2 and proinflammatory cytokine expression in cultured dermal cells","volume":"106","author":"Murakami","year":"2022","journal-title":"J Dermatol Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.3390\/jcm13061602","article-title":"The psychology of atopic dermatitis","volume":"13","author":"Courtney","year":"2024","journal-title":"J Clin Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3390\/jpm12060893","article-title":"From skin barrier dysfunction to systemic impact of atopic dermatitis: implications for a precision approach in dermocosmetics and medicine","volume":"12","author":"Maintz","year":"2022","journal-title":"J Pers Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pbb.2019.05.005","article-title":"Neuroinflammation as a risk factor for attention deficit hyperactivity disorder","volume":"182","author":"Dunn","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"key":"B42","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3389\/fpsyt.2017.00228","article-title":"Attention-Deficit\/Hyperactivity disorder and inflammation: what does current knowledge tell US? A systematic review","volume":"8","author":"Anand","year":"2017","journal-title":"Front Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1159\/000489635","article-title":"A review on the role of inflammation in attention-deficit\/hyperactivity disorder","volume":"25","author":"Leffa","year":"2018","journal-title":"Neuroimmunomodulation"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.4049\/jimmunol.159.6.2994","article-title":"Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease","volume":"159","author":"Mittleman","year":"1997","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"941413","DOI":"10.1155\/2015\/941413","article-title":"IL-4 Inhibits IL-1\u03b2-induced depressive-like behavior and central neurotransmitter alterations","volume":"2015","author":"Park","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B46","doi-asserted-by":"publisher","first-page":"309","DOI":"10.5607\/en.2018.27.4.309","article-title":"Interleukin-4 contributes to degeneration of dopamine neurons in the lipopolysaccharide-treated substantia Nigra in vivo","volume":"27","author":"Bok","year":"2018","journal-title":"Exp Neurobiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/brainsci6020018","article-title":"Neuroimmunology of the interleukins 13 and 4","volume":"6","author":"Mori","year":"2016","journal-title":"Brain Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1084\/jem.20091419","article-title":"Regulation of learning and memory by meningeal immunity: a key role for IL-4","volume":"207","author":"Derecki","year":"2010","journal-title":"J Exp Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12888-026-07785-9","article-title":"Atopic dermatitis and psychological disorders in children and adolescents: a systematic review on comorbidities and mechanism","volume":"26","author":"Zhu","year":"2026","journal-title":"BMC Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2483370","DOI":"10.1080\/07853890.2025.2483370","article-title":"Bidirectional association between atopic dermatitis and attention deficit hyperactivity disorder: a systematic review and meta-analysis","volume":"57","author":"Wang","year":"2025","journal-title":"Ann Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.psyneuen.2012.09.017","article-title":"Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit\/hyperactivity disorder","volume":"38","author":"Buske-Kirschbaum","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"18079","DOI":"10.2147\/JIR.S578036","article-title":"The neuroimmune axis in atopic dermatitis: from pathogenic mechanisms to targeted neuroimmunotherapy","volume":"18","author":"Zhang","year":"2025","journal-title":"J Inflamm Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/nyas.15299","article-title":"Short-chain fatty acids mediate gut microbiota-brain communication and protect the blood-brain barrier integrity","volume":"1545","author":"Chenghan","year":"2025","journal-title":"Ann N Y Acad Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s40257-020-00538-8","article-title":"The role of the microbiome and microbiome-derived metabolites in atopic dermatitis and non-histaminergic itch","volume":"21","author":"Li","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pediatrneurol.2025.07.017","article-title":"Gut Microbiota-derived short-chain fatty acids and sleep disturbances in pediatric attention-deficit\/hyperactivity disorder: insights into neurobiological links and treatment implications","volume":"172","author":"Boonchooduang","year":"2025","journal-title":"Pediatr Neurol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1504065","DOI":"10.3389\/fnana.2025.1504065","article-title":"Exploring the microbiota-gut-brain axis: impact on brain structure and function","volume":"19","author":"Yassin","year":"2025","journal-title":"Front Neuroanat"},{"key":"B57","doi-asserted-by":"publisher","first-page":"103493","DOI":"10.1016\/j.mcn.2020.103493","article-title":"Short-chain fatty acids (SCFAs) alone or in combination regulate select immune functions of microglia-like cells","volume":"105","author":"Wenzel","year":"2020","journal-title":"Mol Cell Neurosci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"7954","DOI":"10.1021\/acs.jafc.4c00205","article-title":"Dietary galacto-oligosaccharides ameliorate atopic dermatitis-like skin inflammation and behavioral deficits by modulating gut Microbiota-brain-skin axis","volume":"72","author":"Tang","year":"2024","journal-title":"J Agric Food Chem"},{"key":"B59","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/all.14690","article-title":"EAACI Biologicals guidelines-dupilumab for children and adults with moderate-to-severe atopic dermatitis","volume":"76","author":"Agache","year":"2021","journal-title":"Allergy"},{"key":"B60","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jaad.2023.01.025","article-title":"Dupilumab treatment for atopic dermatitis is associated with decreased utilization of psychostimulants for attention deficit hyperactivity disorder: a retrospective cohort study","volume":"88","author":"Yildirim","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s40265-025-02151-7","article-title":"Stapokibart: first approval","volume":"85","author":"Shirley","year":"2025","journal-title":"Drugs"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1111\/ijd.17820","article-title":"Stapokibart rapidly and consistently improves the clinical signs across all body regions in adults with moderate-to-severe atopic dermatitis","volume":"64","author":"Zhao","year":"2025","journal-title":"Int J Dermatol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/all.16368","article-title":"Long-term efficacy and safety of stapokibart for moderate-to-severe atopic dermatitis: 52-week results from a phase 3 trial","volume":"80","author":"Zhao","year":"2025","journal-title":"Allergy"},{"key":"B64","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/bjd\/ljaf455","article-title":"Safety and efficacy of stapokibart, an anti-IL-4R\u03b1 monoclonal antibody, in children aged 6\u201311 years with moderate-to-severe atopic dermatitis: an open-label, single-arm phase 1b\/2a trial","volume":"194","author":"Zhao","year":"2025","journal-title":"Br J Dermatol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/bjd\/ljaf347","article-title":"Rademikibart monotherapy for moderate-to-severe atopic dermatitis in a 1-year, randomized phase II trial (SEASIDE CHINA): initial 2-week dosing, followed by 2-week or 4-week dosing","volume":"194","author":"Zhang","year":"2026","journal-title":"Br J Dermatol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"6903760","DOI":"10.1155\/dth\/6903760","article-title":"Efficacy and safety of GR1802 in patients with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 2 trial","volume":"2025","author":"Wang","year":"2025","journal-title":"Dermatol Ther"},{"key":"B67","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/17103568251388478","article-title":"MG-K10, a long-acting anti-IL-4 receptor alpha monoclonal antibody in adult patients with moderate-to-severe atopic dermatitis","volume":"37","author":"Gu","year":"2026","journal-title":"Dermat Contact Atopic Occup Drug."},{"key":"B68","doi-asserted-by":"publisher","first-page":"adv15771","DOI":"10.2340\/actadv.v104.15771","article-title":"Characterization of paediatric prurigo nodularis: a multicentre retrospective, observational study","volume":"104","author":"Kyvayko","year":"2024","journal-title":"Acta Derm Venereol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12016-025-09097-4","article-title":"Targeting IL-4\/IL-13 signaling pathways in chronic rhinosinusitis with nasal polyps: from mechanisms to therapies","volume":"68","author":"Chen","year":"2025","journal-title":"Clin Rev Allergy Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.2147\/JIR.S471963","article-title":"Preclinical development of SHR-1819, a potent humanized IL-4R\u03b1 antibody for treating type 2 inflammatory diseases","volume":"17","author":"Zhao","year":"2024","journal-title":"J Inflamm Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1007\/s13555-023-01010-1","article-title":"Safety, pharmacokinetics and preliminary efficacy of IL4-r\u03b1 monoclonal antibody AK120 in both healthy and atopic dermatitis subjects: a phase I, randomized, two-part, double-blind, placebo-controlled, dose-escalation, first-in-human clinical study","volume":"13","author":"Wynne","year":"2023","journal-title":"Dermatol Ther"},{"key":"B72","doi-asserted-by":"publisher","first-page":"100258","DOI":"10.1016\/j.xjidi.2024.100258","article-title":"A bispecific, tetravalent antibody targeting inflammatory and pruritogenic pathways in atopic dermatitis","volume":"4","author":"Tietz","year":"2024","journal-title":"JID Innov Skin Sci Mol Popul Health"},{"key":"B73","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.bbi.2024.04.028","article-title":"Active secretion of IL-33 from astrocytes is dependent on TMED10 and promotes central nervous system homeostasis","volume":"119","author":"Jiao","year":"2024","journal-title":"Brain Behav Immun"},{"key":"B74","doi-asserted-by":"publisher","first-page":"A7432","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A7432","article-title":"Preclinical characterization of IBI3002, an anti-IL-4R\u03b1 and anti-TSLP bispecific antibody that potently dampens inflammatory response and alleviates asthma in mice","volume":"211","author":"Xiong","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.3390\/biomedicines12081818","article-title":"Differences in the interleukin profiles in inattentive ADHD prepubertal children are probably related to conduct disorder comorbidity","volume":"12","author":"Gonz\u00e1lez-Vill\u00e9n","year":"2024","journal-title":"Biomedicines"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1007\/s12325-023-02753-1","article-title":"Efficacy and safety of dupilumab treatment with concomitant topical corticosteroids in children aged 6 months to 5 years with severe atopic dermatitis","volume":"41","author":"Paller","year":"2024","journal-title":"Adv Ther"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1466372","DOI":"10.3389\/fimmu.2024.1466372","article-title":"Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis","volume":"15","author":"Kamal","year":"2024","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/pde.15398","article-title":"Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: a systematic review and meta-analysis","volume":"40","author":"Xu","year":"2023","journal-title":"Pediatr Dermatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/pde.70285","article-title":"Safety of dupilumab and risk of cutaneous T-cell lymphoma in pediatric patients with atopic dermatitis: a data-driven guide to counseling patients and families","author":"Buethe","year":"2026","journal-title":"Pediatr Dermatol"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2026.1887240\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:39:43Z","timestamp":1783661983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2026.1887240\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":79,"alternative-id":["10.3389\/falgy.2026.1887240"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2026.1887240","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"article-number":"1887240"}}